ProQR Therapeutics NV (NASDAQ:PRQR)
| 2.89 Delayed Data As of Feb 08 |  -0.12 / -4.00%Today’s Change | 0.53 Today|||52-Week Range 6.15 | -21.89% Year-to-Date |
Institutional investors purchased a net $1.6 million shares of PRQR during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 28.95% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Other institutional | 16.73% |
| Mutual fund holders | 12.22% |
| Individual stakeholders | -- |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | BMO ASSET MANAGEMENT CORP. Bought 101.5 Thousand shares of ProQR Therapeutics NV |
| 12/31/2022 | SIMPLEX TRADING LLC Bought 32.9 Thousand shares of ProQR Therapeutics NV |
| 12/31/2022 | BMO ASSET MANAGEMENT, INC. Bought 1.1 Thousand shares of ProQR Therapeutics NV |
Top 10 Owners of ProQR Therapeutics NV
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Privium Fund Management BV | 7.50% | 5,344,446 | 19,774,450 | 0 | 0.00% |
| Adage Capital Management LP | 4.63% | 3,300,000 | 12,210,000 | 0 | 0.00% |
| Opaleye Management, Inc. | 4.37% | 3,115,000 | 11,525,500 | +375,000 | +13.69% |
| Prosight Management LP | 2.41% | 1,716,290 | 6,350,273 | +8,781 | +0.51% |
| FIL Investment Advisors (UK) Ltd. | 1.26% | 899,257 | 3,327,251 | -158,834 | -15.01% |
| DAFNA Capital Management LLC | 0.91% | 649,383 | 2,402,717 | +649,383 | -- |
| Macquarie Investment Management B... | 0.87% | 620,000 | 2,294,000 | 0 | 0.00% |
| Renaissance Technologies LLC | 0.83% | 590,568 | 2,185,102 | -338,432 | -36.43% |
| De Grote Voskuil Capital BV | 0.77% | 550,000 | 2,035,000 | +100,000 | +22.22% |
| Morgan Stanley & Co. LLC | 0.64% | 458,991 | 1,698,267 | +79,813 | +21.05% |
Top 10 Mutual Funds Holding ProQR Therapeutics NV
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Aescap Life Sciences | 6.69% | 4,765,659 | 17,632,938 | +1,618,176 | +51.41% |
| JPMorgan Funds - Thematics - Gene... | 1.35% | 961,511 | 3,557,591 | +255,975 | +36.28% |
| Fidelity Funds SICAV - European S... | 1.26% | 899,252 | 3,327,232 | +2 | +0.00% |
| Delaware Healthcare Fund | 0.87% | 620,000 | 2,294,000 | 0 | 0.00% |
| Hoofbosch Beleggingsfonds | 0.77% | 550,000 | 2,035,000 | +100,000 | +22.22% |
| Xtrackers SICAV - MSCI World Swa... | 0.46% | 328,364 | 1,214,947 | 0 | 0.00% |
| CI Global Health Sciences Corpora... | 0.45% | 321,360 | 1,189,032 | 0 | 0.00% |
| Blue Planet Investment Trust Plc | 0.13% | 91,151 | 337,259 | 0 | 0.00% |
| United Global Healthcare Fund | 0.11% | 76,349 | 282,491 | +7,112 | +10.27% |
| Xtrackers SICAV - S&P 500 Swap UC... | 0.08% | 56,844 | 210,323 | 0 | 0.00% |